Dolby Laboratories (DLB) Change in Accured Expenses (2009 - 2026)

Dolby Laboratories (DLB) has reported Change in Accured Expenses for 18 consecutive years, with -$47.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 38.01% year-over-year to -$47.3 million; the trailing twelve-month figure through Jun 2026 stood at $107.4 million (up 4085.2% YoY), and the FY2025 full-year result was $22.9 million, up 166.13% from the prior year.
• Change in Accured Expenses declined to -$47.3 million in Q2 2026 per DLB's latest filing, from $39.3 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $71.8 million in Q3 2025 and bottomed at -$105.3 million in Q2 2023.
• Historically, Change in Accured Expenses has averaged -$1.6 million across 5 years, with a median of $6.7 million in 2022.
• The widest YoY moves for Change in Accured Expenses: up 935.69% in 2023, down 1469.91% in 2023.
• Over 5 years, Change in Accured Expenses stood at $5.8 million in 2022, then tumbled by 654.95% to -$32.0 million in 2023, then jumped by 115.02% to $4.8 million in 2024, then surged by 807.06% to $43.6 million in 2025, then sank by 208.46% to -$47.3 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$47.3 million, $39.3 million, and $43.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.